HIGHLIGHTS
- who: Spyros Chalkias and colleagues from the s Hospital have published the research: LB750, in the Journal: (JOURNAL) of October/20,/2022
SUMMARY
Weill Cornell Medicine, New York, NY Abstract citation ID: ofac492.1873 Conclusions. The bivalent omicron containing mRNA-1273.214 elicited superior nAb responses against omicron 28 days post-immunization compared to mRNA-1273 regardless of age and prior SARS-CoV-2 infection; no new safety concerns were identified. @@
ACRONYMS
LAY DEFINITIONS
Licence: cc-by
Site reference:
If you want to have access to all the content you need to log in! Thanks :)
If you don't have an account, you can create one here. 